Overview

Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis

Status:
Not yet recruiting

Trial end date:
2024-04-01

Target enrollment:

Participant gender:

Summary

This is an open-label study to evaluate the effects of bimekizumab in patients with psoriasis vulgaris and who also have active psoriatic arthritis (PsA).

Phase:

Phase 4

Details

Lead Sponsor:

Innovaderm Research Inc.

Collaborator:

Ciusss de L'Est de l'Île de Montréal